Beauty’s New Price Logic in a Fractured Economy
Luxury beauty price cuts describe a wave of strategic discounting and portfolio reshuffles by prestige, masstige and mass brands that are lowering effective prices, simplifying assortments and reallocating investment in order to keep growth alive as consumer spending splits between affluent shoppers who still trade up and budget-conscious shoppers who are trading down or out of the category altogether.
In a K-shaped economy, beauty is no longer a straight ladder from drugstore lip balm to four-figure creams; it is a forked road where some consumers climb higher into ultra-luxury while many more step sideways into cheaper, “good enough” options. That split is forcing groups like LVMH to rewrite their playbook. The company is “trying to cushion the blow of luxury beauty’s slowdown, driven by economic pressures and weakening consumer spending,” and that reality, not some sudden love of generosity, sits behind most beauty brand discounts today.
LVMH’s Beauty Shakeup: Trading One Kind of Luxury for Another
When the biggest luxury player starts behaving like a value investor, the market should pay attention. LVMH has shed around €100 billion (approx. USD 116 billion / RM535.6 billion) in market value over the past year as luxury demand cools and the base of high-end shoppers, especially in China, shrinks. Its fragrances and cosmetics division is feeling that chill, with sales falling even as its beauty retailer continues to help cushion the blow. The response is not to double down blindly on ultra-premium, but to re-balance the portfolio toward where growth still exists.
According to sources familiar with the matter, MarcyPen Capital Partners, an investment firm backed by Jay-Z and managing about USD 1.1 billion (approx. RM5.08 billion) in assets, is pursuing LVMH’s 50 percent stake in Fenty Beauty. Last year, people familiar with the matter said Fenty could be valued between USD 1–2 billion (approx. RM4.62–9.24 billion) after generating roughly USD 450 million (approx. RM2.08 billion) in net sales in 2024. Offloading a star brand is not a retreat; it is a signal that even icons must earn their keep in a slower, harsher market.
From High-Touch Counters to Target Shelves: The Masstige Pivot
Behind the headlines about potential divestments is a quieter, more telling move: a tilt toward accessibly priced, clinically framed skin care that suits masstige beauty strategy more than old-school luxury. Dermatologist-developed brand Remedy has secured USD 20 million (approx. RM92.4 million) in Series A funding led by L Catterton, the LVMH-affiliated consumer-focused firm with about USD 40 billion (approx. RM184.8 billion) in equity capital. That money is earmarked to deepen formulation and testing capabilities, grow consumer education and build a scaled dermocosmetic platform.
This is not charity toward cash-strapped shoppers; it is tactical investment where the demand is spiking. Remedy plans to use the funds to advance clinical research, expand its pipeline of dermatologist-developed products and improve inventory depth to meet rising demand across direct-to-consumer, Amazon and Target. In plain terms, LVMH-linked capital is following the shopper from luxury department stores to mass retail aisles, betting that affordable, clinically grounded skin care will be a growth engine in a K-shaped economy.
Price Cuts as a Competitive Weapon, Not a Plea for Volume
Tactical deflation and beauty brand discounts are often misunderstood as desperate grabs for volume. In today’s fractured market, they are better seen as weapons in a tiered war for share. As aspirational consumers retreat, full-price luxury risks becoming a niche for the ultra-wealthy. By contrast, masstige and mass brands can grow by shaving margins, simplifying packaging and widening distribution, making each price point feel like a deliberate choice rather than a compromise.
LVMH’s own moves show this logic. The company is exploring options for assets like Make Up For Ever and Fresh while enforcing cost discipline and margin protection. At the same time, it is willing to back brands whose promise is “affordable, clinically-grounded skin care,” as one L Catterton partner described Remedy’s positioning. The message to the rest of the industry is blunt: pricing power is no longer guaranteed; it has to be earned with proof, access and a clear reason to spend more.
What Comes Next: AI, Assortment and the New Beauty Middle
The beauty shakeout is not only about labels changing hands; it is about how big groups plan to win the next decade of consumption. With demand cooling in key markets and the aspirational base thinning, LVMH may now be leaning on AI to defend margins. If AI-powered forecasting can cut dead inventory and sharpen promotional timing, price cuts can be more surgical, less damaging to long-term brand equity and more aligned with real consumer behavior.
Expect the middle of the market to harden, not hollow out. The most successful brands will likely be those that treat every tier—luxury, masstige, mass—as parts of one system, shifting investment and pricing with ruthless clarity instead of romantic attachment to old prestige myths. The conclusion is uncomfortable but clear: in a K-shaped economy, beauty brands that cling to static pricing and rigid positioning will shrink; those that treat price as a live strategic lever will write the next chapter of luxury and mass beauty alike.
